My Personal Therapeutics and Pentavere receive Eureka funding
My Personal Therapeutics, a London-based medtech/digital therapeutics company and Pentavere Research Group, a Canadian-based Artificial Intelligence and data insight company have been awarded Eurkela Collaborative R&D funding for artificial intelligence and quantum technologies. The funding is for a project titled: Utilisation of AI to develop Personalised Treatment Plans for cancer. Funding totalling £792,000 (Euro 870,000) […]
